| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3193145 | Annals of Allergy, Asthma & Immunology | 2008 | 7 Pages |
Abstract
Daily sublingual-oral dosing of standardized allergenic extracts at maximum tolerable doses was generally well tolerated. These results are a first step toward establishing the safety of US-licensed SLIT extracts when appropriately self-administered and monitored.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Robert E. PhD, Robert K. MD, David MD, Richard F. MD,